Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -27.99%84.6M | 5.26%199.34M | 20.39%117.48M | 15.11%189.38M | 3.37%97.58M | -12.66%164.52M | 3.18%94.4M | 14.48%188.37M | 55.78%91.49M | -13.92%164.55M |
| Operating income | -27.99%84.6M | 5.26%199.34M | 20.39%117.48M | 15.11%189.38M | 3.37%97.58M | -12.66%164.52M | 3.18%94.4M | 14.48%188.37M | 55.78%91.49M | -13.92%164.55M |
| Cost of sales | 19.63%-55.46M | -8.52%-127.94M | -17.86%-69.01M | -20.62%-117.89M | -17.05%-58.55M | 17.64%-97.74M | 8.04%-50.02M | -40.65%-118.68M | -57.93%-54.4M | 6.37%-84.37M |
| Operating expenses | 19.63%-55.46M | -8.52%-127.94M | -17.86%-69.01M | -20.62%-117.89M | -17.05%-58.55M | 17.64%-97.74M | 8.04%-50.02M | -40.65%-118.68M | -57.93%-54.4M | 6.37%-84.37M |
| Gross profit | -39.89%29.14M | -0.12%71.41M | 24.18%48.47M | 7.05%71.49M | -12.05%39.03M | -4.17%66.78M | 19.62%44.38M | -13.07%69.69M | 52.75%37.1M | -20.65%80.17M |
| Selling expenses | 15.08%-20.12M | 8.85%-47.66M | -4.05%-23.69M | -6.08%-52.29M | 6.18%-22.77M | 9.62%-49.29M | 3.83%-24.27M | -64.59%-54.53M | -66.81%-25.23M | 33.96%-33.13M |
| Administrative expenses | 21.87%-15.79M | -4.26%-41.81M | -9.00%-20.21M | -11.76%-40.1M | 0.15%-18.54M | -3.33%-35.88M | -11.87%-18.57M | 6.08%-34.72M | 18.20%-16.6M | -10.68%-36.97M |
| Research and development expenses | -80.94%-807K | 55.24%-717K | ---446K | 19.90%-1.6M | ---- | ---2M | ---- | ---- | ---- | ---- |
| Impairment and provision | ---- | -220.69%-93K | ---- | ---29K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -220.69%-93K | ---- | ---29K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -50.94%-1.61M | 0.94%-2.42M | ---1.07M | ---2.44M |
| Special items of operating profit | 115.78%752K | -447.28%-43.5M | -647.93%-4.77M | -736.43%-7.95M | -60.54%870K | 253.82%1.25M | 778.49%2.21M | -120.60%-812K | 1,773.33%251K | 212.11%3.94M |
| Operating profit | -966.09%-6.82M | -104.70%-62.38M | 54.45%-640K | -59.23%-30.47M | -165.78%-1.41M | 16.05%-19.14M | 138.49%2.14M | -297.08%-22.8M | 50.21%-5.55M | -38.22%11.57M |
| Financing cost | 11.35%-1.4M | -0.29%-2.81M | -20.38%-1.58M | 0.11%-2.8M | ---1.31M | ---2.8M | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---51K | 99.77%-4K | ---- | -967.48%-1.74M | 54.49%-81K | -7.24%-163K | ---178K | ---152K | ---- | ---- |
| Share of profit from joint venture company | 70.00%-12K | ---72K | ---40K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -267.04%-8.28M | -86.40%-65.26M | 19.28%-2.26M | -58.41%-35.01M | -242.80%-2.8M | 3.69%-22.1M | 135.29%1.96M | -298.39%-22.95M | 55.08%-5.55M | -29.42%11.57M |
| Tax | -59.19%-1.18M | 172.01%1.99M | 43.08%-740K | -249.35%-2.77M | 31.51%-1.3M | -60.40%1.85M | -1,825.45%-1.9M | 170.34%4.68M | -80.87%110K | -8.92%-6.66M |
| After-tax profit from continuing operations | -215.72%-9.46M | -67.46%-63.26M | 26.83%-3M | -86.59%-37.78M | -6,926.67%-4.1M | -10.85%-20.25M | 101.10%60K | -471.94%-18.27M | 53.82%-5.44M | -52.21%4.91M |
| Earning after tax | -215.72%-9.46M | -67.46%-63.26M | 26.83%-3M | -86.59%-37.78M | -6,926.67%-4.1M | -10.85%-20.25M | 101.10%60K | -471.94%-18.27M | 53.82%-5.44M | -52.21%4.91M |
| Minority profit | -37.10%-1.89M | 23.88%-4.05M | 25.04%-1.38M | -22.74%-5.32M | -29.47%-1.84M | -654.09%-4.34M | -603.96%-1.42M | -187.12%-575K | -190.58%-202K | 73.68%660K |
| Profit attributable to shareholders | -368.15%-7.57M | -82.43%-59.21M | 28.29%-1.62M | -103.99%-32.46M | -252.16%-2.26M | 10.06%-15.91M | 128.30%1.48M | -516.16%-17.69M | 56.36%-5.24M | -57.05%4.25M |
| Basic earnings per share | -325.00%-0.0136 | -64.59%-0.1111 | 31.91%-0.0032 | -77.17%-0.0675 | -771.43%-0.0047 | -348.24%-0.0381 | 128.00%0.0007 | -440.00%-0.0085 | 64.29%-0.0025 | -59.02%0.0025 |
| Diluted earnings per share | -325.00%-0.0136 | -64.59%-0.1111 | 31.91%-0.0032 | -77.17%-0.0675 | -771.43%-0.0047 | -348.24%-0.0381 | 128.00%0.0007 | -440.00%-0.0085 | 64.29%-0.0025 | -59.02%0.0025 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.